Breethe Abiomed Recovery RegisTry (BART)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05473130

Acronym

BART

Enrollment

Registered

2022-07-25

Start date

2021-03-31

Completion date

2024-04-02

Last updated

2024-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS, Cardiopulmonary Bypass, Heart Failure

Keywords

Breethe Oxy-1 System, Extracorporeal Membrane Oxygenation, Cardiopulmonary bypass, ARDS, Heart failure

Brief summary

The BART Registry intended to utilize observational data of the Abiomed Breethe OXY-1 System™ in real-world settings to drive best practice usage patterns, serve as a tool to measure and improve the quality of patient care and as a resource to inform us on the design of future studies.

Interventions

DEVICEBreethe Oxy-1 System

To pump, oxygenate, and remove carbon dioxide from blood during cardiopulmonary bypass with Breethe Oxy-1 System

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* all adult subjects supported with Breethe Oxy-1 System

Exclusion criteria

* subjects under 18 years of age

Design outcomes

Primary

Measure	Time frame
Survival up to the hospital discharge	Up to the hospital discharge, an average of 2 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026